James W. McCollum, a director at LENZ Therapeutics ($LENZ), made one open market purchase of shares in the last year, totaling $239 thousand. His most recent buy occurred on November 7, 2025. This ranks him 1,403rd among 4,983 insiders by purchase value, well below the average of $1.5 million over 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2025 | LENZ Therapeutics, Inc. | $LENZ | MCCOLLUM JAMES W | Director | P | Common Stock | 10500 | $22.79 | 631,099.0000 | 31,289,969 | 1.69% | 0.03% |
| June 11, 2025 | LENZ Therapeutics, Inc. | $LENZ | MCCOLLUM JAMES W | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 27,542,874 | 9999.99% | 0.05% |
| May 13, 2024 | LENZ Therapeutics, Inc. | $LENZ | MCCOLLUM JAMES W | Director | P | Common Stock | 31332 | $15.99 | 620,599.0000 | 0 | 5.32% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | MCCOLLUM JAMES W | Director | A | Common Stock | 95034 | $0.00 | 589,267.0000 | 0 | 19.23% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | MCCOLLUM JAMES W | Director | A | Common Stock | 477600 | $0.00 | 572,634.0000 | 0 | 502.56% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | MCCOLLUM JAMES W | Director | A | Common Stock | 16633 | $15.03 | 589,267.0000 | 0 | 2.90% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | MCCOLLUM JAMES W | Director | A | Warrant (right to buy) | 6575 | $0.00 | 6,575.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | MCCOLLUM JAMES W | Director | A | Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |